Home > Journals > Acta Vulnologica > Past Issues > Acta Vulnologica 2007 September;5(3) > Acta Vulnologica 2007 September;5(3):105-11

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

ACTA VULNOLOGICA

A Journal on Physiopathology and Therapy of Chronic Cutaneous Ulcers


Official Journal of the Italian Association for Cutaneous Ulcers
Indexed/Abstracted in: EMBASE, Scopus, Emerging Sources Citation Index


eTOC

 

ORIGINAL ARTICLES  


Acta Vulnologica 2007 September;5(3):105-11

language: Italian

Askina Calcitrol Ag: clinical use of an advanced antiseptic medication

Ricci E., Pittarello M., Cassino R., Moffa M., Ferrero S., Gonella M., Tonini E.

UOA Ferite Difficili Casa di Cura San Luca, Pecetto Torinese (TO)


PDF  


Askina Calcitrol Ag¨ (B-Braun) is a two-layer medication: one layer in polyurethane foam which allows wound exudates to be absorbed, one contact layer in alginate containing Ag ions which are released in a humid environment. Thirty-seven patients with infected or critically colonised wounds, but without any profound infection requiring general antibiotic treatment, were recruited for the study. The parameters analysed were: pain; evolution of the bacterial population measured by tampon; variations in the lesion surface area (Visitrak system), development of the infection. The infection picture was defined by means of clinical criteria according to Harading and according to Sibbald. Medication was changed at saturation and the observation period was two weeks. An improvement with resolution of the infection within 14 days was observed in 34/37, pain when changing medication was present, especially at the first medications. The variation in bacterial populations was present right from the first week. Performance in terms of patient/operator comfort proved to be very high.

top of page

Publication History

Cite this article as

Corresponding author e-mail